Anti-B7-H6 / NCR3LG1 Reference Antibody (Dartmouth patent anti-B7-H6)
- Product Code: 139826
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in cancer immunotherapy research to target the B7-H6/NCR3LG1 immune checkpoint pathway. This antibody binds specifically to B7-H6, a protein often overexpressed on tumor cells, helping to block immune evasion and enhance natural killer (NK) cell activation against cancers. It serves as a reference tool for developing therapeutic antibodies and diagnostic assays. Also utilized in mechanistic studies to understand tumor-immune interactions and in the design of antibody-drug conjugates or bispecific antibodies for targeted cancer treatment.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | Ft50,976.37 |
+
-
|
Anti-B7-H6 / NCR3LG1 Reference Antibody (Dartmouth patent anti-B7-H6)
Used in cancer immunotherapy research to target the B7-H6/NCR3LG1 immune checkpoint pathway. This antibody binds specifically to B7-H6, a protein often overexpressed on tumor cells, helping to block immune evasion and enhance natural killer (NK) cell activation against cancers. It serves as a reference tool for developing therapeutic antibodies and diagnostic assays. Also utilized in mechanistic studies to understand tumor-immune interactions and in the design of antibody-drug conjugates or bispecific antibodies for targeted cancer treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :